In patients with atrophic OLP, Desmoulins may have been released to promote keratinocyte differentiation and the upregulation of p53, and this antigenic expression could have led to the development of antibodies against desmogleins and autoimmunity. The gene discussed is TP53; the disease is Autoimmunity.